Chen Zhong, Ni Jia-lian, Liu Lu-yue
Department of Hepatobiliary Surgery, Jinan Militaty Area Command Hospital, Jinan, China.
Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):710-3.
To analyze the prognostic factors in patients after surgical resection of a huge primary liver cancer (HPLC).
Clinical and follow-up data of 69 cases of huge HPLC treated in our hospital from July 2001 to July 2008 were retrospectively analyzed. Sixteen clinicopathologic factors possibly influencing the survival were selected, and multivariate analysis of these parameters was performed using the Cox proportional hazards model.
The cumulative 1-, 3-, 5-year survival rates of 58 patients were 58.2%, 31.4% and 12.3%, respectively. Univariate analysis showed that radical resection, intrahepatic metastasis, vascular invasion and degree of hepatic cirrhosis significantly affect the postoperative survival. The Cox multivariate analysis indicated that radical resection, intrahepatic metastasis and degree of hepatic cirrhosis are independent prognostic factors.
Surgical resection is a major and active treatment for huge HPLC. The therapeutic efficacy depends on intrahepatic metastasis, degree of hepatic cirrhosis and radical resection. Aggressive treatment and prevention on postoperative intrahepatic recurrence and metastasis is an important strategy to improve the survival of patients with huge HPLC.
分析巨大原发性肝癌(HPLC)手术切除患者的预后因素。
回顾性分析2001年7月至2008年7月在我院接受治疗的69例巨大HPLC患者的临床及随访资料。选取16个可能影响生存的临床病理因素,采用Cox比例风险模型对这些参数进行多因素分析。
58例患者的1年、3年、5年累积生存率分别为58.2%、31.4%和12.3%。单因素分析显示,根治性切除、肝内转移、血管侵犯和肝硬化程度显著影响术后生存。Cox多因素分析表明,根治性切除、肝内转移和肝硬化程度是独立的预后因素。
手术切除是巨大HPLC的主要积极治疗方法。治疗效果取决于肝内转移、肝硬化程度和根治性切除。积极治疗和预防术后肝内复发和转移是提高巨大HPLC患者生存率的重要策略。